2025 Annual Earnings Summary
| Category | 2024 | 2025 | Change (YoY) |
|---|---|---|---|
| Revenue | 42,599 | 46,232 | +8.5% |
| Operating Profit | 2,493 | 3,680 | +47.6% |
[Amorepacific Holdings Consolidated Performance] (Unit: KRW 100 million / Growth rate: Year-over-Year)
Amorepacific Group posted consolidated revenue of KRW 4.6232 trillion and operating profit of KRW 368 billion for the year 2025, marking its highest operating profit in six years since 2019. Improved performance was driven by strengthened competitiveness across the group's global premium skincare brands, strong performance in derma, makeup and hair care categories, and continued expansion in major overseas markets. As execution of the mid- to long-term corporate vision, 'Create New Beauty,' gained momentum, Amorepacific Group further reinforced its foundation to advance as a global leader in beauty and wellness.
Leading Subsidiary: Amorepacific
| Category | Total | Domestic | Overseas | |||
|---|---|---|---|---|---|---|
| Revenue | 42,528 | +9% | 22,752 | +5% | 19,091 | +15% |
| Operating Profit | 3,358 | +52% | 1,449 | -2% | 2,099 | +102% |
[Amorepacific Consolidated Performance] (Unit: KRW 100 million / Growth rate: Year-over-Year)
Amorepacific, the group's leading subsidiary, continued to propel the group's consolidated results, delivering 9.5% year-over-year revenue growth and a 52.3% surge in operating profit. LANEIGE expanded its product portfolio to strengthen brand influence across key overseas markets. AESTURA, Korea's leading derma brand, accelerated global market entry and sustained high growth in the derma category. Sulwhasoo maintained growth momentum and solidified its leadership in the luxury skincare market. COSRX completed the restructuring of its distribution network and returned to revenue growth in the fourth quarter, led in particular by the newly incubated 'The Peptide' line. In hair care, Mise-en-Scène and RYO achieved results not only in the domestic market but also in North America and Greater China, contributing to category growth alongside LABO-H and COSRX's hair care line. Mise-en-Scène Perfect Serum secured the No.1 ranking in the hair styling oil category during Amazon's Black Friday event.
Amorepacific's domestic business achieved 5% revenue growth year-over-year, while operating profit declined 2% (taking into account expenses related to a voluntary retirement program). Core domestic channels—online, MBS, and department stores—continued to grow steadily, while duty-free and cross-border channels (a business model in which the domestic headquarters collaborates directly with overseas distributors and retailers for local market entry) also maintained growth momentum. Sulwhasoo enhanced competitiveness in the luxury gifting market through differentiated services such as the Jihambo gift-wrapping offering. Mamonde expanded its influence among Gen Z and Gen Alpha consumers in the domestic market following its successful rebranding, and entered the European market through cross-border channels. HERA reinforced its positioning as Korea's leading luxury makeup brand by leveraging its standing as the No.1 cushion foundation brand in the domestic market and expanding into the Japanese department store channel.
Amorepacific's overseas business delivered growth across all regions, with revenue rising 15% and operating profit surging 102% year-over-year. In the Americas, revenue grew 20%, supported by strong demand for LANEIGE lip and skincare products, the launch of new brands including AESTURA and HANYUL, and solid sales of COSRX's 'The Peptide' skincare line. In EMEA, revenue increased 42% driven by expanded customer touchpoints for LANEIGE and INNISFREE, as well as COSRX's fourth-quarter rebound. Greater China turned to profitability following improvements in business structure, while Japan and APAC posted strong growth led by LANEIGE, derma brands (ILLIYOON and AESTURA), and hair care (Mise-en-Scène).
Other Major Subsidiaries: INNISFREE, ETUDE, espoir, AMOS PROFESSIONAL, OSULLOC
| Subsidiary | INNISFREE | ETUDE | espoir | |||
|---|---|---|---|---|---|---|
| Revenue | 2,098 | -7% | 1,151 | +7% | 772 | +10% |
| Operating Profit | 133 | +716% | 100 | +10% | -5 | Loss |
| Subsidiary | AMOS PROFESSIONAL | OSULLOC | ||||
| Revenue | 791 | -0.1% | 1,109 | +18% | ||
| Operating Profit | 70 | -37% | 115 | +25% | ||
[Major Subsidiaries Performance] (Unit: KRW 100 million / Growth rate: Year-over-Year)
Other major subsidiaries of Amorepacific Holdings also contributed to the group's growth. INNISFREE improved profitability through channel portfolio restructuring. ETUDE delivered growth in both revenue and operating profit on the back of strong performance in core makeup categories such as lip and mascara, and expansion into cross-border channels. espoir and AMOS PROFESSIONAL continued balanced growth across online and offline channels. OSULLOC, which has strengthened its presence as a luxury tea brand by leading the matcha trend, surpassed KRW 100 billion in annual revenue for the first time since its spin-off, and increased operating profit by 25%.
Strategic Progress and Outlook: 'Create New Beauty'
In 2025, Amorepacific Group accelerated the execution of its 'Everyone Global' agenda by sustaining high growth in North America and EMEA, stabilizing its business structure and improving profitability in the Greater China region, maintaining solid growth in Japan and APAC, and enabling faster entry into new markets through cross-border channels. The group also strengthened its position in the derma category led by AESTURA, expanded makeup category leadership through the performance of key brands including HERA, ETUDE and espoir, and led high growth in hair care supported by RYO, Mise-en-Scène and LABO-H, further enhancing its competitiveness in holistic beauty & wellness solutions.
Under its mid- to long-term vision 'Create New Beauty,' Amorepacific Group continues to pursue leadership in the global beauty & wellness industry. The group is advancing five strategic priorities: global core markets (Everyone Global); integrated beauty solutions (Holistic); biotechnology-based anti-aging innovation (Ageless); agile organizational transformation (AMORE Spark) and; AI-based work transformation (AI First).
[Q4 2025 Performance Summary]
| Category | Q4 2024 (KRW 100 million) |
Q4 2025 (KRW 100 million) |
Change (YoY) |
|
|---|---|---|---|---|
| Amorepacific Holdings |
Revenue | 11,794 | 12,552 | +6% |
| Operating Profit | 790 | 548 | -31%* | |
| Amorepacific | Revenue | 10,917 | 11,634 | +7% |
| Operating Profit | 785 | 525 | -33%* | |